HEARTio
PrivateLast Round
Seed
Mar 16, 2026
Total Funding Raised
$5.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HEARTio operates in Healthcare & Life Sciences and is based in Pittsburgh, Pennsylvania. Its latest recorded funding round was a Seed round in March 2026.
HEARTio is a healthtech company that develops an AI-powered diagnostic platform to detect coronary artery disease using electrocardiogram (ECG) data.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Revenue Share, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HEARTio Comparables
Compare HEARTio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Powerful Medical | 80% | |
| 9+1AI | 79% | |
| Anumana | 79% |
For institutional investors. Book with your work email.
HEARTio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 16, 2026 | ||||
| Pre Seed | Dec 4, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HEARTio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Audacious Capital | Seed |
| LifeX Global | Seed |
| Bessel | Seed |
| Richard King Mellon Foundation | Pre Seed |
| Intelligence Ventures | Seed |
| VU Venture Partners | Seed |
| Big Idea Advantage Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 101% MoM, reaching 4.8K.
- Jun 2, 2026
Grew 55% QoQ from 11 to 17 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 18, 2026
Heart Input Output, Inc. is developing investigational artificial intelligence software that analyzes a standard electrocardiogram to estimate obstructive coronary artery disease without dyes, radiation, incisions or catheters.
For institutional investors. Book with your work email.
HEARTio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HEARTio's valuation, stock price, and market status.
Is HEARTio a public or private company?
HEARTio is a private company.
What is the current stock price of HEARTio?
HEARTio is a private company, so its shares have no public market price. Caplight tracks HEARTio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HEARTio worth (valuation)?
Valuation information for HEARTio is not publicly available.
Can I buy HEARTio stock?
HEARTio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HEARTio's last funding round?
HEARTio's most recent funding round was Seed on March 16, 2026.
Who are the main investors in HEARTio?
Key investors in HEARTio include Audacious Capital, LifeX Global, Bessel, Richard King Mellon Foundation, Intelligence Ventures.
Will HEARTio IPO soon?
No public IPO plans have been announced for HEARTio.
How can I track HEARTio secondary market activity?
Caplight tracks bids, offers, and trades in HEARTio's shares on secondary markets.